Skip to content
HeyJared

Few & Far Between: How Biotech Gets Built

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.

Podcast · By Chris O'Brien · English · Official site

Indexed episodes, last 90 days
1
Latest publication
Aug 11, 2026
Audience
Checking…
Earliest in this view
Aug 11, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest episodes

  1. Episode · Aug 11, 2026

    Episode 73: Isaac Stoner, CEO, MindImmune Therapeutics, Inc. (opens the original)

    Episode notes · Positive tone

    Read excerpt

    Today on the Biorasi Few & Far Between podcast: Host Melissa Alesse welcomes Isaac Stoner, CEO of MindImmune Therapeutics, back to the podcast for a conversation on the evolving science of Alzheimer's disease and the challenges of biotech leadership. We'll explore Alzheimer's through the lens of the immune system, discuss drug development from the perspective of investors and operators, and dive into the power of networking in Boston's biotech ecosystem. And be sure to stick around for our light

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Few & Far Between: How Biotech Gets Built